Sign in

CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company

ATOSSA THERAPEUTICS, INC.

Sign in to watch
Ticker
ATOS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
264753208
Phone
206.588.0256
Business address
1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
Former names
ATOSSA GENETICS INC
  1. 8-K Event Regulation FD disclosure
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 8-K Event Shareholder vote results
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. DEF 14A Proxy Proxy Statement
  11. PRE 14A Proxy Proxy Statement (Preliminary)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 10-K Report Annual Report
  15. 8-K Event Results of operations · Executive or director change
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G Stake Amended Statement of Ownership
  18. SC 13G Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 10-Q Report Quarterly Report

Page 9 of 33 · 643 filings